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SUPPLEMENTARY DATA 
SUPPLEMENTARY BACKGROUND 
Importantly, glucose-derived glycerol is endogenously synthesized in the skin (mostly 
in the sebaceous glands) and was suggested to play a crucial role in the homeostatic 
regulation of the skin barrier (4,6-8). Indeed, in asebia mice with impaired sebaceous 
gland functions and hence a dramatically suppressed (by 85%) endogenous glycerol 
production, decreased SC hydration was observed which was completely reverted by 
application of exogenous glycerol (7). Likewise, hydration in the human skin was also 
found to be correlated with endogenous glycerol levels in the SC (9). Therefore, it is 
proposed that the highly beneficial effects of topically applied glycerol in a multitude 
of skin conditions (e.g. dry skin syndromes such as winter xerosis, irritative skin 
syndromes, dermatoses with impaired barrier, atopic dermatitis, etc.) is due to its 
“replacement actions” by normalizing endogenous glycerol-controlled homeostatic 
cutaneous mechanisms. 
 
The cutaneous effects of glycerol were mostly (if not exclusively) attributed to its 
physico-chemical properties. Endogenously produced or exogenously applied 
glycerol penetrates to keratinocytes located in the basal layer(s) of the epidermis via 
aquaglyceroporin AQP3 pores and, due to its humectancy or hygroscopicity, 
promotes the establishment and maintenance of the epidermal barrier (4-6,8). 
Indeed, in AQP3-deficient mice with decreased SC hydration and pathological barrier 
(4,10), application of glycerol improved skin hydration and accelerated barrier 
recovery (8). 
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SUPPLEMENTARY EXPERIMENTAL DESIGN 
Cell culturing 
Human abdominal skin samples were collected after written informed consent from 
dermatologically healthy individuals (18-73 years old females and males), undergoing 
surgical intervention, adhering to Helsinki guidelines and after obtaining Institutional 
Research Ethics Committee’s and National Public Health and Medical Officer Service 
- Office of the Chief Medical Officer’s permission (protocol No.: DE OEC RKEB/IKEB 
3724-2012; document No.: IX-R-052/01396-2/2012). NHEKs were isolated after 
overnight dermo-epidermal separation in 2.4 IU/ml dispase (Roche Diagnostics, 
Berlin, Germany) by short trypsin (0.05%, Sigma-Aldrich, St. Louis, MO) digestion. 
Cells were cultured in EpiLife serum free medium (Invitrogen, Paisley, UK) 
supplemented with 1 μM insulin, 1 μM cortisol (both from Sigma-Aldrich), 100 μg/ml 
streptomycin, 100 U/ml penicillin, 50 ng/ml amphotericin B, 0.4% bovine pituitary 
extract (all from Invitrogen) and 0.06 mM CaCl2 (Sigma-Aldrich) (21). In order to 
achieve “pre-confluent” cultures, 500,000 cells were seeded in 35 mm Petri dishes, 
and the appropriate treatments were initiated on the day after, whereas in case of 
those cultures, which were to be investigated in post-confluent state, culture medium 
was exchanged daily until the cultures reached 100% confluence (i.e. for ca. 3-4 
days), when the indicated treatments were executed. In each experiment, cells of the 
same donor were used for both the pre- and the post-confluent experiments. 
 
Overview of the TLR-activation-induced pro-inflammatory models 
Lipopolysaccharide (LPS; TLR4 activator), lipoteichoic acid (LTA; TLR2 activator) 
and polyinosinic-polycitidylic acid (poly-(I:C); TLR3 activator) were dissolved in 
filtered distilled water; all substances were purchased from Sigma-Aldrich. Pre-
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confluent cultures of NHEKs were treated with these substances w/wo glycerol or 
xylitol for 3 hrs (simultaneous treatments), and then RNA samples were collected for 
subsequent analyses. 
 
Determination of viability 
The viability was determined by measuring the conversion of the tetrazolium salt 
(methylthiazolyldiphenyl-tetrazolium bromide, MTT; Sigma-Aldrich) to formazan by 
mitochondrial dehydrogenases (21,22). Cells were plated in 96-well plates (10,000 
cells/well density) in quadruplicates, and were treated with xylitol (0.0045-0.45%) or 
glycerol (0.0027-0.27%) for various time intervals. Cells were then incubated with 0.5 
mg/ml MTT for 2 hrs, and concentration of formazan crystals was determined 
colorimetrically according to the manufacturer’s protocol. 
 
Determination of cell death 
A decrease in the mitochondrial membrane potential is one of the earliest markers of 
apoptosis. Therefore, to assess the process, mitochondrial membrane potential of 
NHEKs was determined using a MitoProbe™ DiIC1(5) Assay Kit (Life Technologies, 
Carlsbad, CA, USA). Cells (20,000 cells/well) were cultured in 96-well black-
well/clear-bottom plates (Greiner Bio One, Frickenhausen, Germany) in 
quadruplicates and were treated with various compounds. After removal of 
supernatants, cells were incubated for 30 minutes with DilC1(5) working solution (50 
μl/well), then washed with PBS (115 mM NaCl, 206 mM Na2PO4, pH 7.4; all from 
Sigma-Aldrich), and the fluorescence of DilC1(5) was measured at 630 nm excitation 
and 670 nm emission wavelengths using a FlexStation 3 FLuorescence Image 
MicroPlate Reader (FLIPR; Molecular Devices, San Francisco, CA). 
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Necrotic processes were determined by SYTOX Green staining (Life Technologies). 
The dye is able to penetrate (and then bind to the nucleic acids) only to necrotic cells 
with ruptured plasma membranes, whereas healthy cells with intact surface 
membranes show negligible SYTOX Green staining. Cells were cultured in 96-well 
black-well/clear-bottom plates (Greiner Bio One), and treated with polyols. 
Supernatants were then discarded, and the cells were incubated for 30 minutes with 
1 μM SYTOX Green dye. Following incubation, cells were washed with PBS, the 
culture medium was replaced, and fluorescence of SYTOX Green was measured at 
490 nm excitation and 520 nm emission wavelengths using FLIPR (Molecular 
Devices) (21,22). 
 
Quantitative Real-Time PCR (Q-PCR) 
To determine the quantitative expressions of various markers at the mRNA level, Q-
PCR was performed on an ABI Prism 7000 sequence detection system (Applied 
Biosystems, Foster City, CA) using the 5’ nuclease assay as detailed in our previous 
reports (21-24). In brief, total RNA was isolated using TRIzol (Invitrogen) and 3 μg of 
total RNA were reverse-transcribed into cDNA by using 15 IU of AMV reverse 
transcriptase (Promega, Madison, WI, USA) and 0.025 μg/μl random primers 
(Promega). PCR amplification was performed by using TaqMan primers and probes 
(Applied Biosystems). As internal controls, transcripts of cyclophilin A (PPIA) were 
determined. Assay ID-s of the applied primer probes are overviewed in 
Supplementary Table S1.  
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Western blotting 
To determine the activation of the Erk1/2 MAPK, as well as the expressional 
alteration of loricrin at the protein level, the Western blot technique was applied 
(22,25). Cell lysates of keratinocytes were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (8% gels were loaded with 30 μg protein per 
lane), transferred to BioBond nitrocellulose membranes (Whatman, Maidstone, UK), 
and then probed with primary antibodies against loricrin, Erk1/2 and phospho-Erk1/2 
(1:500, all from Sigma-Aldrich). A horseradish peroxidase-conjugated IgG antibody 
(1:1000, Bio-Rad, Hercules CA, USA) was used as a secondary antibody, and the 
immunoreactive bands were visualized by a SuperSignal® West Pico 
Chemiluminescent Substrate enhanced chemiluminescence kit (Pierce, Rockford, IL, 
USA) using LAS-3000 Intelligent Dark Box (Fuji, Tokyo, Japan). In case of loricrin, to 
assess equal loading, membranes were re-probed with an anti-β-actin antibody 
(1:2000, Santa Cruz, CA, USA) and visualized as described above. Immunoblots 
were then subjected to densitometric analysis using an Intelligent Dark Box (Fuji, 
Tokyo, Japan) and the ImageJ 1.49v software (NIH, Bethesda, MD, USA). In case of 
Erk1/2 activation 100 nM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) was 
employed as positive control. 
 
Ca2+-imaging 
Changes in intracellular calcium concentration ([Ca2+]i) upon applications of the 
polyols were detected by fluorimetric Ca2+-imaging (21,26,27). Cells were seeded in 
96-well black-well/clear-bottom plates (Greiner Bio One) at a density of 10,000 
cells/well and then were incubated with culturing medium containing the cytoplasmic 
calcium indicator 2 µM Fluo-4 AM (Invitrogen) at 37°C for 40 min. The cells were 
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washed four times with and finally kept in Hank’s solution containing 1% bovine 
serum albumin and 2.5 mM Probenecid (both from (Sigma-Aldrich) for 30 min at 37 
°C. The plates were then placed to FLIPR (Molecular Devices) and changes in [Ca2+]i 
(reflected by changes fluorescence; lEX=494 nm, lEM=516 nm) induced by the 
indicated treatments were recorded in each well. 
 
Immunocytochemistry, confocal microscopy 
Human keratinocytes, seeded and cultured on sterile coverslips in 24-well plates, 
were fixed in acetone, permeabilized by 0.1% Triton-X-100 (Sigma-Aldrich), and then 
incubated with rabbit primary antibodies against PKCα (Sigma-Aldrich) or PKCδ 
(Santa Cruz) (1:200 dilution in both cases). For fluorescence staining, slides were 
then incubated with fluorescein-isothiocyanate (FITC) conjugated secondary 
antibodies (dilution 1:200, Vector Laboratories, Burlingame, CA, USA) and the nuclei 
were visualized using DAPI (Vector Laboratories). In course of the optimization of the 
staining protocols, as negative controls, the appropriate antibody was either omitted 
from the procedure or was pre-incubated with synthetic blocking peptides (data not 
shown); for details, see our previous studies (27,28). 
 
To assess the translocation of the PKC isoforms (reflecting activation of the 
enzymes), the above labeling was performed on cells which were previously treated 
by 0.27% glycerol or 0.45% xylitol for various time intervals. FITC-labeled cells were 
then subjected to a visualization procedure using a Zeiss LSM 510 confocal 
microscopy (Oberkochen, Germany) (25). 
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Statistical analysis 
When applicable, data were analyzed using Student’s unpaired, two-tailed t-test and 
P<0.05 values were regarded as significant differences.  
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SUPPLEMENTARY CONCLUSIONS 
 
Here we provide the first evidence that glycerol and xylitol exert profound effects on 
gene expressions and the activities of various signaling pathways of NHEKs. The 
observed differential effects of xylitol and glycerol are astounding, since both polyols 
have high water sorption capacity (7). However, since these two polyols exerted 
different effects when applied at identical osmolarities, we propose that some of their 
actions may be mediated not exclusively by their physico-chemical properties. 
 
First, we showed that both polyols (without affecting viability of the cells; 
Supplementary Figure S1) significantly up-regulated the expression of various 
differentiation markers (Figure 1). Indeed, both glycerol and xylitol markedly 
upregulated expression of filaggrin and loricrin, key molecules of the epidermal 
barrier (30,s1), both in the proliferating and differentiating keratinocytes (Figure 1). 
Likewise, both polyols significantly increased the expression of occludin (Figure 1), 
an important molecule in the formation of epidermal barrier junctions (s2,s3). 
Interestingly, only xylitol was able to significantly upregulate the level of involucrin 
(Figure 1), another key molecule participating in epidermal differentiation. These 
findings collectively implicate that the cutaneous barrier-repairing and differentiation-
promoting effects of xylitol might be superior to those of glycerol. Interestingly, 
however, when tested at the protein level, glycerol appeared to be more efficient than 
xylitol in upregulating loricrin expression in already differentiating NHEKs (48-hr 
treatments; Supplementary Figure S2). Although data of this pilot experiment 
performed on cells of one single donor await to be confirmed on multiple donors, they 
highlight that i) cellular effects of the polyols may well be donor-dependent ones; and 
ii) mRNA level findings cannot necessarily be directly translated to the protein level. 
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In a wider sense, it is interesting to note that the gylcerol-conducting pore AQP3 is 
expressed at the basolateral membrane of colonic epithelial cells, too, and its 
knockdown caused a dramatic, dose-dependent increase in E. coli C25 translocation, 
with the reduction of transepithelial electrical resistance (TEER) and increasing LY (a 
fluorescent dye) permeability. Of great importance, expression of claudin-1 and 
occludin were significantly decreased in the AQP3 knockdown group, demonstrating 
that knockdown of AQP3 (maybe leading to inappropriate glycerol uptake and 
signaling?) might impair the intestinal barrier integrity via dysregulating occludin 
expression (s4). On the other hand, cellular effects of glycerol might even be dose-
dependently opposing ones, since an injection of high dose (10%) glycerol solution 
led to an overall suppression of spermatogenesis in rats. Importantly, an equi-
osmolar solution of glucose also resulted in significant suppression of 
spermatogenesis, but the effect of glycerol was significantly greater, suggesting a 
mechanism in addition to hyperosmolarity (s5), and indeed, in a more recent study, 
glycerol treatment disrupted tight junction-associated F-actin and occludin and tubulin 
organization in rat Sertoli cells (s6). 
 
Interestingly, similarities and differences were also observed when we attempted to 
uncover the effects of the polyols on the cellular signaling pathways known to be 
involved in the regulation of epidermal growth and differentiation. As revealed by 
functional imaging, neither polyol altered the intracellular calcium homeostasis of the 
cells (Supplementary Figure S3). This implies that their pro-differentiating effects 
are most probably not mediated by the elevation of [Ca2+]i, which is one of the key 
events in the induction of terminal differentiation of epidermal keratinocytes (35). The 
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lack of the involvement of [Ca2+]i was also suggested by that neither polyol affected 
subcellular localization of the calcium-dependent PKCα (reflecting lack of activation; 
Supplementary Figure S4), which enzyme was shown to be involved in the [Ca2+]i-
mediated differentiation of NHEKs (36). However, xylitol (but not glycerol) was able to 
induce the translocation of the Ca2+-independent PKCδ (Figure 2A). Since we have 
previously shown that (similar to PKCα) PKCδ promoted differentiation of human 
epidermal keratinocytes (37), this intriguing finding suggested that the more 
pronounced pro-differentiating and barrier-promoting effect of xylitol over glycerol 
might have been mediated by the additional involvement of PKCδ-coupled signaling. 
Finally, we have also presented that both polyols activated the Erk1/2 MAPK pathway 
(Figure 2B), another molecular system controlling keratinocyte growth and survival 
(38,39). 
 
Of further importance, differential effects of the two polyols could also be identified 
when we assessed their actions in various TLR-mediated inflammation (40) and 
irritation keratinocyte models (Supplementary Tables S2-S10). Although their 
efficiencies were found to be donor- and cytokine-dependent ones, and xylitol 
appeared to be more potent in most cases, we found that both polyols could prevent 
TLR-activation-induced upregulation of several pro-inflammatory cytokines (IL-1α, IL-
1β, TNFα). Moreover, both glycerol and xylitol decreased the up-regulation of HLA-
DR, a marker of immune activation (41,42). 
 
Although our current data provide an important new insight to the mechanism of 
action of these polyols (activation of the MAPK cascade by both of them; activation of 
PKCδ by xylitol), it should also be noted that since glycerol (and in low amounts even 
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xylitol) can be produced in the human body, it is possible that administration of such 
compounds exerts biological effects not only via their physicochemical properties, 
and activation/inhibition of several cellular signaling pathways, but they might also 
have a direct biochemical impact on the cellular metabolism and (at least in vivo) 
even on the microbiota-skin cross-talk, too. 
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Supplementary Tables 
 
Supplementary Table S1 Overview of the primer probes used for the Q-PCR analyses 
 
Gene symbol Gene name Assay ID 
FLG Filaggrin Hs00856927_g1 
LOR Loricrin Hs01894962_s1 
IVL Involucrin Hs00846307_s1 
OCLN Occludin Hs00170162_m1 
HLA-DRA 
Major histocompatibility 
complex, class II, DR alpha 
Hs00219575_m1 
IL1α Interleukin 1α Hs00174092_m1 
IL1β Interleukin 1β Hs00174097_m1 
IL6 Interleukin 6 Hs00985639_m1 
IL8 Interleukin 8 Hs00174103_m1 
IL18 Interleukin 18  
TNFα Tumor necrosis factor α Hs00174128_m1 
MMP1 Matrix metalloproteinase 1 Hs00899658_m1 
MMP9 Matrix metalloproteinase 9 Hs00234579_m1 
PPIA 
Peptidylprolyl Isomerase A 
(cyclophilin A) 
Hs99999904_m1 
 
 
Supplementary Tables (ST) S2-S10 Effects of polyols on expressions of various 
inflammation markers 
 
Keratinocytes from nine donors were treated with various TLR activators – i.e. 10 μg/ml 
lipoteichoic acid (LTA, TLR2 activation model); 20 μg/ml polyinosinic:polycytidylic acid (poly-
IC, pIC; TLR3 activation model); 5 μg/ml lipopolysaccharide (LPS, TLR4 activation model) – 
with or without glycerol (0.27%) and xylitol (0.45%). The mRNA expressions of multiple pro-
inflammatory interleukins (IL), tumor necrosis factor-α (TNFa), and matrix metalloproteases 
(MMP) as well as the keratinocyte immunoactivation marker HLA-DR were then assessed by 
Q-PCR. Data were analyzed using the ΔΔCT method. Tables present PPIA-normalized fold-
change values where the value of the vehicle control was set as 1. Data represent triplicate 
determinations in each experiment. 
 
Green font, green background: significant (P<0.05) down-regulation compared to the 
respective inducer agent (LTA, pIC or LPS) treated group. 
Black font, yellow background: tendencies towards down-regulation. 
Red font, white background: tendencies towards up-regulation. 
Red font, red background: significant (P<0.05) up-regulation compared to the respective 
inducer agent (LTA, pIC or LPS) treated group. 
N/D: not determined 
U/I: unidentified 
Not induced: ≤1.5-fold up-regulation compared to the control group in the inducer (LTA, pIC 
or LPS) treated group. 
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ST2 
HLA-DRA 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl 1 1 1 U/I U/I U/I U/I U/I 1.00 
LPS 
Not 
induced 
Not 
induced 
Not 
induced 
U/I U/I U/I U/I U/I 
Not 
induced 
LPS+Gly U/I U/I U/I U/I U/I 
LPS+Xyl U/I U/I U/I U/I U/I 
LTA 
Not 
induced 
1.76 
Not 
induced 
U/I U/I U/I U/I U/I 
Not 
induced 
LTA+Gly 1.04 U/I U/I U/I U/I U/I 
LTA+Xyl 1.05 U/I U/I U/I U/I U/I 
pIC 
Not 
induced 
8.38 2.86 U/I U/I U/I U/I U/I 
Not 
induced 
pIC+Gly 3.76 1.05 U/I U/I U/I U/I U/I 
pIC+Xyl 1.59 2.00 U/I U/I U/I U/I U/I 
 
ST3 
IL-1α 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl 1 1 1 1 1 1 1 1 1 
LPS 2.71 
Not 
induced 
Not 
induced 
Not 
induced 
1.63 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
LPS+Gly 2.38 1.66 
LPS+Xyl 1.15 1.62 
LTA 3.19 
Not 
induced 
2.10 
Not 
induced 
1.68 1.99 
Not 
induced 
1.64 
Not 
induced 
LTA+Gly 3.17 2.13 1.66 1.64 1.94 
LTA+Xyl 1.66 1.47 1.57 1.76 1.57 
pIC 1.86 3.37 1.92 
Not 
induced 
1.88 
Not 
induced 
2.01 1.98 1.93 
pIC+Gly 1.32 3.59 1.33 1.26 2.05 2.19 1.58 
pIC+Xyl 1.27 2.40 1.45 1.53 1.97 2.24 2.79 
 
ST4 
IL-1β 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl 1 1 1 1 1 1 1 1 1 
LPS 6.91 
Not 
induced 
Not 
induced 
Not 
induced 
1.75 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
LPS+Gly 7.62 1.84 
LPS+Xyl 2.41 1.78 
LTA 8.88 1.59 3.17 
Not 
induced 
1.93 
Not 
induced 
2.36 1.55 1.58 
LTA+Gly 10.74 1.86 3.32 1.83 2.14 1.56 1.49 
LTA+Xyl 3.74 2.14 3.62 1.75 1.81 1.37 1.52 
pIC 4.21 13.44 4.57 
Not 
induced 
2.78 
Not 
induced 
1.86 2.32 2.59 
pIC+Gly 2.90 16.49 4.37 1.11 1.50 2.17 1.75 
pIC+Xyl 0.78 9.06 3.83 2.33 2.70 1.83 3.72 
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ST5 
IL-6 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl 1.00 N/D 1 1 1 1 1 1 1 
LPS 
Not 
induced 
N/D 
Not 
induced 
2.72 1.67 
Not 
induced 
Not 
induced 
Not 
induced 
2.42 
LPS+Gly N/D 2.11 2.10 1.88 
LPS+Xyl N/D 2.25 1.14 1.36 
LTA 1.86 N/D 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
LTA+Gly 0.90 N/D 
LTA+Xyl 1.69 N/D 
pIC 2.00 N/D 11.88 18.19 115.45 
Not 
induced 
7.51 44.43 14.55 
pIC+Gly 1.18 N/D 70.92 10.17 177.28 13.13 48.56 5.82 
pIC+Xyl 2.17 N/D 12.75 13.70 62.09 6.31 41.87 13.26 
 
ST6 
IL-8 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl 1 N/D 1 1 1 1 1 1 1 
LPS 
Not 
induced 
N/D 1.82 4.71 1.84 
Not 
induced 
4.25 
Not 
induced 
Not 
induced 
LPS+Gly N/D 0.87 5.55 2.74 2.54 
LPS+Xyl N/D 6.22 6.63 2.47 3.54 
LTA 
Not 
induced 
N/D 7.37 1.80 
Not 
induced 
Not 
induced 
3.59 2.15 
Not 
induced 
LTA+Gly N/D 38.32 1.96 3.04 2.99 
LTA+Xyl N/D 54.10 1.44 4.09 2.31 
pIC 
Not 
induced 
N/D 241.40 4.51 8.96 1.77 22.09 33.03 12.64 
pIC+Gly N/D 790.02 4.02 12.18 1.94 41.58 41.71 13.46 
pIC+Xyl N/D 531.63 8.91 12.65 2.14 31.57 49.23 16.00 
 
ST7 
IL-18 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl 1 1 1 1 1 1 1 1 1 
LPS 11.81 
Not 
induced 
1.52 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
3.91 
LPS+Gly 9.50 1.72 2.70 
LPS+Xyl 4.22 2.44 1.79 
LTA 5.32 
Not 
induced 
1.55 
Not 
induced 
Not 
induced 
Not 
induced 
2.54 
Not 
induced 
1.54 
LTA+Gly 12.19 1.63 2.42 1.58 
LTA+Xyl 3.82 2.39 1.96 2.18 
pIC 3.08 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
pIC+Gly 3.74 
pIC+Xyl 1.30 
 
  
16 
 
ST8 
TNFα 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl N/D 1 1 N/D N/D 1 1 1 1 
LPS N/D 
Not 
induced 
Not 
induced 
N/D N/D 
Not 
induced 
3.12 1.67 
Not 
induced 
LPS+Gly N/D N/D N/D 1.77 1.22 
LPS+Xyl N/D N/D N/D 2.20 1.64 
LTA N/D 
Not 
induced 
Not 
induced 
N/D N/D 
Not 
induced 
1.58 1.65 
Not 
induced 
LTA+Gly N/D N/D N/D 1.28 1.79 
LTA+Xyl N/D N/D N/D 1.74 1.99 
pIC N/D 24.65 14.49 N/D N/D 1.87 10.87 33.39 12.26 
pIC+Gly N/D 21.88 11.44 N/D N/D 1.71 10.48 35.28 6.36 
pIC+Xyl N/D 8.86 6.37 N/D N/D 0.78 11.92 25.37 16.46 
 
ST9 
MMP1 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl N/D 1 1 N/D N/D 1 1 1 1 
LPS N/D 
Not 
induced 
Not 
induced 
N/D N/D 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
LPS+Gly N/D N/D N/D 
LPS+Xyl N/D N/D N/D 
LTA N/D 1.73 5.72 N/D N/D 
Not 
induced 
1.79 
Not 
induced 
1.52 
LTA+Gly N/D 1.67 4.97 N/D N/D 1.08 1.05 
LTA+Xyl N/D 4.18 7.72 N/D N/D 1.83 1.52 
pIC N/D 3.13 1.59 N/D N/D 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
pIC+Gly N/D 2.85 1.22 N/D N/D 
pIC+Xyl N/D 3.75 2.26 N/D N/D 
 
ST10 
MMP9 
Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 
ctrl N/D 1 1 N/D N/D 1 1 1 1 
LPS N/D 
Not 
induced 
Not 
induced 
N/D N/D 
Not 
induced 
Not 
induced 
Not 
induced 
Not 
induced 
LPS+Gly N/D N/D N/D 
LPS+Xyl N/D N/D N/D 
LTA N/D 
Not 
induced 
Not 
induced 
N/D N/D 
Not 
induced 
1.93 
Not 
induced 
Not 
induced 
LTA+Gly N/D N/D N/D 0.64 
LTA+Xyl N/D N/D N/D 1.16 
pIC N/D 102.69 23.16 N/D N/D 
Not 
induced 
Not 
induced 
Not 
induced 
1.57 
pIC+Gly N/D 149.50 13.47 N/D N/D 0.96 
pIC+Xyl N/D 29.45 9.22 N/D N/D 2.33 
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SUPPLEMENTARY FIGURES 
 
 
Supplementary Figure S1 Polyols do not affect viability and proliferation of NHEKs 
Pre-confluent (i.e. proliferating) NHEKs were treated with glycerol and xylitol in 
quadruplicates as indicated for 72 hrs, and then MTT assays were performed to 
assess viability and growth rate of the cells. Data are expressed as mean±SEM. 
Three repeated experiments yielded similar results. 
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Supplementary Figure S2 Glycerol up-regulates the expression of loricrin 
Western blot analysis of lysates of post-confluent (i.e. differentiating) NHEKs of one 
donor. Cells were treated with glycerol (0.27%) and xylitol (0.45%) for 48 hrs, and 
then the protein level expression of loricrin was assessed (loading control: β-actin). 
OD: β-actin-normalized optical density of the corresponding bands were normalized 
to the value of the control group. 
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Supplementary Figure S3 Polyols do not elevate [Ca2+]i of NHEKs 
Fluorimetric Ca2+ imaging using Fluo-4. Glycerol (0.27%) and xylitol (0.45%) were 
applied as indicated by the arrow. As a positive control, ATP (180 μM) was applied 
[s7]. Fluorescence (measured in relative fluorescence units) was normalized to the 
baseline. Two additional series of experiments yielded similar results. 
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Supplementary Figure S4 Neither polyol induce the translocation of PKCα in 
NHEKs 
Confocal microscopy. NHEKs were treated with vehicle (Control) or with Glycerol 
(0.27%) and xylitol (0.45%) for the time indicated, then immunofluorescent staining of 
PKCα was performed. Images were acquired by a laser scanning confocal 
microscope using the “z-stack mode” with strictly the same antibody staining and 
visualization procedure (the second image from the level of the coverslips). Note the 
lack of translocation after treatment with polyols. Bars: 10 μm. Two additional 
experiments yielded similar results. 
 
  
30 min 60 min10 min
30 min 60 min10 min
Glycerol
Xylitol
Control
21 
 
 
Supplementary Figure S5 Polyols do not suppress ATP or bradykinin (BK)-induced 
elevation of [Ca2+]i of NHEKs 
Fluorimetric Ca2+ imaging using Fluo-4. Glycerol (gly; 0.27%) and xylitol (xyl; 0.45%) 
were applied 30 min before ATP (180 μM) (A); or bradykinin (BK 30 μM) (B) 
treatments. Mean±SEM of peak F/F0 values of 6 parallel determinations of one donor 
are plotted. One additional experiment (performed on cells of an additional donor) 
yielded similar results. 
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